What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Gene
His scientific interests lie mostly in Genetics, Internal medicine, Genome-wide association study, Single-nucleotide polymorphism and Genetic variation.
His work in Gene, Allele, Mutation, Genetic association and Genome are all subfields of Genetics research.
His Internal medicine research includes elements of Gastroenterology, Surgery and Oncology.
His studies in Genome-wide association study integrate themes in fields like Case-control study and Genetic architecture.
David Goldstein usually deals with Single-nucleotide polymorphism and limits it to topics linked to Candidate gene and Haplotype.
His Genetic variation research incorporates themes from Evolutionary biology, Natural selection and Population genetics.
His most cited work include:
- Finding the missing heritability of complex diseases. (6217 citations)
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine (3192 citations)
- Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group (3088 citations)
What are the main themes of his work throughout his whole career to date?
David Goldstein focuses on Internal medicine, Genetics, Oncology, Cancer and Surgery.
His Internal medicine research includes themes of Gastroenterology and Endocrinology.
His Gene, Genetic variation, Genome-wide association study, Exome sequencing and Allele investigations are all subjects of Genetics research.
David Goldstein is involved in the study of Exome sequencing that focuses on Exome in particular.
His study connects Colorectal cancer and Oncology.
His Pancreatic cancer study frequently draws parallels with other fields, such as Cancer research.
He most often published in these fields:
- Internal medicine (25.37%)
- Genetics (16.70%)
- Oncology (14.28%)
What were the highlights of his more recent work (between 2017-2021)?
- Internal medicine (25.37%)
- Oncology (14.28%)
- Gene (7.01%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Internal medicine, Oncology, Gene, Genetics and Exome sequencing.
His work deals with themes such as Peripheral neuropathy and Gastroenterology, which intersect with Internal medicine.
His biological study spans a wide range of topics, including Computational biology and Disease.
Genetics and Epilepsy are commonly linked in his work.
David Goldstein works in the field of Exome sequencing, focusing on Exome in particular.
The study of Pancreatic cancer is intertwined with the study of Cancer research in a number of ways.
Between 2017 and 2021, his most popular works were:
- Dark Energy Survey year 1 results: Cosmological constraints from galaxy clustering and weak lensing (670 citations)
- Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial (396 citations)
- Dark Energy Survey Year 1 results: cosmological constraints from cosmic shear (385 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Gene
- Cancer
His scientific interests lie mostly in Internal medicine, Exome sequencing, Gene, Genetics and Oncology.
His research investigates the connection with Internal medicine and areas like Peripheral neuropathy which intersect with concerns in Incidence, Quality of life and Cancer.
David Goldstein has included themes like Obstetrics, Genetic variation, Bioinformatics and Candidate gene in his Exome sequencing study.
His Genetics study frequently draws connections between adjacent fields such as Amyotrophic lateral sclerosis.
His Oncology study combines topics in areas such as Alzheimer's disease, Cohort study and Adjuvant therapy.
In Pancreatic cancer, David Goldstein works on issues like Gemcitabine, which are connected to Adjuvant.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
